{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-265750","form_type":"8-K","ticker":"INGN","cik":"0001294133","company_name":"Inogen Inc","filed_at":"2025-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.043190+00:00","generated_at":"2026-05-17T00:12:27.101616+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Inogen Q3 revenue $92.4M (+4% YoY); adj. EBITDA positive $2.3M; raises FY guidance","bullets":["Revenue $92.4M, up 4% YoY; seventh consecutive quarter of mid-single-digit growth.","GAAP net loss $5.3M vs $6.0M loss; adjusted net loss $0.5M vs $2.6M loss.","Adjusted EBITDA $2.3M (third consecutive positive quarter); full-year adj. EBITDA guidance raised to ~$2M.","Cash $124.5M, no debt; initiated limited U.S. release of Simeox airway clearance device.","Gross margin 44.7% down from 46.5% due to higher B2B sales mix."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-265750","json":"https://secwatch.observer/filing/0001193125-25-265750.json","markdown":"https://secwatch.observer/filing/0001193125-25-265750.md","text":"https://secwatch.observer/filing/0001193125-25-265750.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1294133/000119312525265750/0001193125-25-265750-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1294133/000119312525265750/ingn-20251105.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T00:12:27.101616+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}